Since the report of the United Nations Commission on Life-saving Commodities for Women and Children (UNCoLSC) was published in 2012, much has been done to highlight the challenges countries face in ensuring the availability of essential commodities and to create resources to assist countries in this endeavor. In most settings, these commodities are procured with government funds, but there is a lack of documented evidence as to how decisions regarding financing for these commodities are made and executed. An understanding of the financial flows for MNCH commodities is critical as countries pursue the goals of ending preventable child and maternal deaths and of universal health coverage and as many go through processes of decentralization. Understanding financial flows for MNCH commodities may also assist the donor community in making smarter investments and assisting countries in mobilizing additional resources. The US Agency for International Development (USAID) commissioned this study in Bangladesh, Nepal, Kenya, and Uganda.
As countries pursue the maternal, newborn, and child health (MNCH) targets established under Sustainable Development Goal 3, they will need to ensure the continuous availability of essential health commodities to prevent and treat the conditions that cause morbidity and mortality in those groups. Since the report of the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC) was published in 2012, much progress has been made to highlight the challenges countries face in ensuring access to essential commodities and to create resources to overcome these challenges. A major issue yet to be adequately addressed is financing for these life-saving commodities. SIAPS mapped the budget allocation, approval, disbursement, and reporting processes in the public sector for essential MNCH commodities in four countries—
Bangladesh, Kenya, Nepal, and Uganda—to inform the development of strategies and
interventions that will improve access to these commodities.
Implementing QuanTB to Improve Forecasting, Supply Planning, and Early Warning Systems for TB Medicines: Uganda Report
SIAPS conducted a review of SIAPS TB technical assistance and the QuanTB implementation in Uganda. Specific objectives were to determine:
- Key achievements or results of the SIAPS QuanTB technical assistance in Uganda
- Experiences and perspectives of the beneficiaries of the NTP
- Challenges and lessons learned
This report summarizes key aspects and results of the Uganda review.
Assessment of Supply Chain Management Systems for Neglected Tropical Disease Drugs in Cameroon, Mali, Tanzania, and Uganda
The rapid expansion of neglected tropical diseases (NTD) control activities has brought about pharmaceutical and health system challenges. In most countries, the Ministry of Health (MoH) is responsible for the administration and operation of medicines supply and distribution and for providing district health administrations with funding from the national level. District health care responsibilities are to implement the national NTD policy, plan and manage mass drug administrations (MDAs), and oversee community administration of the NTD control programs. The purpose of assessing the pharmaceutical management and supply chain management (SCM) of NTD control programs for Cameroon, Mali, Tanzania, and Ugande was to learn about the programs, identify the gaps within their pharmaceutical management, and make recommendations for strengthening the system.
We carried out case studies in Rwanda and Uganda from July to September 2012 to develop the assessment approach. The studies conducted included a desk review of the Uganda National Tuberculosis and Leprosy Program (NTLP), the Rwanda National TB Program (NTP), and ministry of health documents and budgets from both countries.
Pharmacovigilance Activities in HIV and AIDS Programs in Eight Sub-Saharan African Countries: Opportunities to Enhance Treatment Outcomes and Ensure Patient Safety
Monitoring adverse drug reactions is becoming a priority for public health programs involved in large scale-ups of new essential medicines. Under an interagency agreement between the US Food and Drug Administration and the US Agency for International Development (USAI), the SPS program assessed pharmacovigilance activities of 32 PHPs in sub-Saharan Africa. Poster displayed at the International AIDS 2012 conference in Washington DC, 22nd-27th July 2012.
- Rapport de quantification des produits de la santé reproductive, maternelle, néonatale et infantile pour la période de janvier 2017 à décembre 2020
La présente activité avait pour objectif d’apporter un soutien au Ministère de la Santé et de l’Hygiène publique (MSHP) pour […]
Project dates: September 2012 – December 2016
The Department of Health-Pharmaceutical Division (DOH-PD) and National TB Program (NTP) in the Philippines adopted the web‐based application Pharmacovigilance Monitoring […]